| Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence M Bodenlenz, KI Tiffner, R Raml, T Augustin, C Dragatin, T Birngruber, ... Clinical pharmacokinetics 56, 91-98, 2017 | 103 | 2017 |
| A novel human ex-vivo burn model and the local cooling effect of a bacterial nanocellulose-based wound dressing JCJ Holzer, K Tiffner, S Kainz, P Reisenegger, IB de Mattos, M Funk, ... Burns 46 (8), 1924-1932, 2020 | 54 | 2020 |
| A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5% KI Tiffner, I Kanfer, T Augustin, R Raml, SG Raney, F Sinner International journal of pharmaceutics 535 (1-2), 217-227, 2018 | 54 | 2018 |
| Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion. C Dragatin, F Polus, M Bodenlenz, C Calonder, B Aigner, KI Tiffner, ... Experimental dermatology 25 (2), 2016 | 51 | 2016 |
| Open flow microperfusion: An alternative method to microdialysis? T Pieber, T Birngruber, M Bodenlenz, C Höfferer, S Mautner, K Tiffner, ... Microdialysis in Drug Development, 283-302, 2013 | 25 | 2013 |
| Variability of skin pharmacokinetic data: insights from a topical bioequivalence study using dermal open flow microperfusion M Bodenlenz, T Augustin, T Birngruber, KI Tiffner, B Boulgaropoulos, ... Pharmaceutical Research 37, 1-11, 2020 | 18 | 2020 |
| Quantification of basal insulin peglispro and human insulin in adipose tissue interstitial fluid by open-flow microperfusion K Tiffner, B Boulgaropoulos, C Höfferer, T Birngruber, N Porksen, ... Diabetes Technology & Therapeutics 19 (5), 305-314, 2017 | 15 | 2017 |
| Assessment of skin permeability to topically applied drugs by skin impedance and admittance S Schwingenschuh, H Scharfetter, ØG Martinsen, B Boulgaropoulos, ... Physiological measurement 38 (11), N138, 2017 | 14 | 2017 |
| Comparative in vitro release testing (IVRT) of acyclovir products KI Tiffner, I Kanfer, T Augustin, R Raml, SG Raney, F Sinner International Journal of Pharmaceutics 609, 121186, 2021 | 7 | 2021 |
| Dermal Open Flow Microperfusion for PK-based Clinical Bioequivalence Studies of Topical Drug Products F Sinner, T Birngruber, K Tiffner, SI Mautner Frontiers in Pharmacology, 4852, 2022 | 4* | 2022 |
| The anti IL-17A IgG1 antibody distributes in dermal interstitial fluid as demonstrated by using dermal open flow microperfusion after a single 300 mg subcutaneous … G Bruin, C Dragatin, B Aigner, F Polus, C Calonder, C Froeliger, K Tiffner, ... JOURNAL OF INVESTIGATIVE DERMATOLOGY 134, S18-S18, 2014 | 3 | 2014 |
| Skin impedance measurements support ex-vivo penetration studies for topical applied drugs S Schwingenschuh, M Hajnsek, H Scharfetter, ØG Martinsen, K Tiffner, ... Biomedical Engineering/Biomedizinische Technik 58 (SI-1-Track-S …, 2013 | 3 | 2013 |
| Bioequivalence of Topical Products in Excised Human Skin Assessed with dermal Open Flow Microperfusion (dOFM) K Tiffner, M Bodenlenz, D Schimek, P Reisenegger, E Rantou, R Raml, ... Poster presented at: PPP–Perspectives in Percutaneous Penetration. 16th …, 2018 | 2 | 2018 |
| 365 A human ex vivo burn model–its characterization and use for preclinical testing of innovative wound dressings E Hofmann, JC Holzer-Geißler, K Tiffner, A Eberl, T Birngruber, M Funk, ... Journal of Investigative Dermatology 141 (10), S212, 2021 | 1 | 2021 |
| 344 The Cooling Effect of a Bacterial Nanocellulose-Based Wound Dressing on a Burn Injury JC Holzer, K Tiffner, S Kainz, P Reisenegger, A Tuca, M Funk, ... Journal of Burn Care & Research 40 (Supplement_1), S149-S149, 2019 | 1 | 2019 |
| Secukinumab, a novel anti-IL-17A antibody, can be quantified in skin after a single dose by dermal open flow microperfusion (dOFM) G Bruin, C Dragatin, B Aigner, F Polus, C Calonder, C Froeliger, K Tiffner, ... JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 12, 15-15, 2014 | 1 | 2014 |
| Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in … F Monedeiro, B Ehall, K Tiffner, A Eberl, E Svehlikova, B Prietl, V Pfeifer, ... Journal of Proteome Research 23 (8), 3496-3514, 2024 | | 2024 |
| Cutaneous Pharmacokinetics-Based Bioequivalence: A Clinical Dermal Open Flow Microperfusion Verification Study Using Lidocaine and Prilocaine Combination Topical Products KI Tiffner, T Ramezanli, B Boulgaropoulos, T Birngruber, M Bodenlenz, ... European Journal of Pharmaceutical Sciences, 106827, 2024 | | 2024 |
| 120 Interstitial fluid metabolomics shows dupilumab effects in the treatment of atopic dermatitis F Monedeiro, B Ehall, EM Prugger, E Zügner, E Svehlikova, T Pieber, ... Journal of Investigative Dermatology 143 (11), S352, 2023 | | 2023 |
| 96 Dermal open flow microperfusion (dOFM) to monitor local tissue response after dupilumab treatment in lesional and non-lesional skin of atopic dermatitis patients K Tiffner, B Ehall, A Eberl, M Bodenlenz, T Pircher, T Birngruber, F Sinner, ... Journal of Investigative Dermatology 143 (11), S348, 2023 | | 2023 |
Christian DragatinBestätigte E-Mail-Adresse bei dragatin.at
